CMIP and glomerular disorder: In addition, experimental data from several models of podocyte injury suggest that targeting CMIP with specific inhibitors taken up by podocytes may be a promising future therapeutic approach for some glomerular diseases associated with the overproduction of CMIP in podocytes [6, 26].